<autonumout > <autonumout ><autonumout > TABLE OF CONTENTS Page Conflict of Interest Statement 1 - Tirofiban - Document - PDFSEARCH.IO

First Page		Document Content
Date: 1998-05-27 11:51:59 gpIIb/IIIa inhibitors Piperidines Sulfonamides Tirofiban Clinical research Aging-associated diseases Clinical endpoint Percutaneous coronary intervention Heparin Medicine Health Chemistry		TABLE OF CONTENTS Page Conflict of Interest Statement 1 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 299,59 KB Share Document on Facebook

	Appendix B: Inclusion and Exclusion Criteria Inclusion criteria Patients was 20 years old Patients suitable for percutaneous coronary intervention (PCI) DocID: 1t846 - View Document
	Microsoft Word - PMDA-S-薬剤溶出型冠動脈ステント-070715_EE.docx DocID: 1remo - View Document
	Opportunity for Human Research Subjects Cardiovascular Inflammation Reduction Trial (CIRT). A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of ca DocID: 1r6ms - View Document
	AHRQ Quality Indicators™ Inpatient Quality Indicators Assess the quality of care for adults in the hospital Inpatient Quality Indicators— DocID: 1r2Dz - View Document
	NIH Public Access Author Manuscript N Engl J Med. Author manuscript; available in PMC 2014 February 11. NIH-PA Author Manuscript DocID: 1qMu1 - View Document